Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05992311
PHASE1

Clinical Evaluation of Montelukast in Veterans With Gulf War Illness

Sponsor: Baylor College of Medicine

View on ClinicalTrials.gov

Summary

The study addresses the pre-clinical promise of Montelukast (MLK) for improving brain function in veterans with Gulf War Illness (GWI). MLK, a US Food and Drug administration (FDA)-approved drug for asthma, has shown efficacy in an animal model of GWI to improve cognitive and mood function through modulation of leukotriene signaling and suppression of neuroinflammation.

Official title: Clinical Evaluation of Montelukast on Cognitive and Mood Dysfunction and Neuroinflammation in Veterans With Gulf War Illness (GWI)

Key Details

Gender

All

Age Range

50 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2025-08-15

Completion Date

2028-08

Last Updated

2025-08-20

Healthy Volunteers

No

Interventions

DRUG

Montelukast

This group will receive the montelukast treatment.

OTHER

Placebo

This group will receive a placebo pill instead of montelukast

Locations (1)

Michael E. DeBakey VA Medical Center

Houston, Texas, United States